Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent

Anderson, 2004, Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000, J Vasc Surg, 39, 1200, 10.1016/j.jvs.2004.02.039 Goodney, 2009, National trends in lower extremity bypass surgery, endovascular interventions, and major amputations, J Vasc Surg, 50, 54, 10.1016/j.jvs.2009.01.035 Rowe, 2009, Patterns of treatment for peripheral arterial disease in the United States: 1996-2005, J Vasc Surg, 49, 910, 10.1016/j.jvs.2008.11.054 Gray, 1997, High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty, J Vasc Surg, 25, 74, 10.1016/S0741-5214(97)70323-9 Conroy, 2000, Angioplasty and stent placement in chronic occlusion of the superficial femoral artery: technique and results, J Vasc Interv Radiol, 11, 1009, 10.1016/S1051-0443(07)61331-1 Gordon, 2001, Three-year outcome of endovascular treatment of superficial femoral artery occlusion, Arch Surg, 136, 221, 10.1001/archsurg.136.2.221 Wolosker, 2003, Primary utilization of stents in angioplasty of superficial femoral artery, Vasc Endovascular Surg, 37, 271, 10.1177/153857440303700406 Mewissen, 2004, Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results, Tech Vasc Interv Radiol, 7, 2, 10.1053/j.tvir.2004.01.007 Sabeti, 2004, Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis, Radiology, 232, 516, 10.1148/radiol.2322031345 Schillinger, 2007, Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting, Circulation, 115, 2745, 10.1161/CIRCULATIONAHA.107.688341 Soga, 2009, Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication, J Am Coll Cardiol, 53, 48, 10.1016/j.jacc.2008.09.020 Iida, 2008, Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions, J Vasc Surg, 48, 144, 10.1016/j.jvs.2008.02.062 Norgren, 2007, Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), Eur J Vasc Endovasc Surg, 33, S1, 10.1016/j.ejvs.2006.09.024 Ranke, 1992, Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction, Ultrasound Med Biol, 18, 433, 10.1016/0301-5629(92)90082-L Rutherford, 1997, Recommended standards for reports dealing with lower extremity ischemia: revised version, J Vasc Surg, 26, 517, 10.1016/S0741-5214(97)70045-4 Rocha-Singh, 2007, Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease, Catheter Cardiovasc Interv, 69, 910, 10.1002/ccd.21104 Kasapis, 2009, Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials, Eur Heart J, 30, 44, 10.1093/eurheartj/ehn514 Werk, 2008, Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial, Circulation, 118, 1358, 10.1161/CIRCULATIONAHA.107.735985 Tepe, 2008, Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg, N Engl J Med, 358, 689, 10.1056/NEJMoa0706356 Pereira, 2006, Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency, J Vasc Surg, 44, 510, 10.1016/j.jvs.2006.04.054 de Vries, 1997, Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis, J Vasc Surg, 26, 558, 10.1016/S0741-5214(97)70053-3 Back, 2001, Utility of duplex surveillance following iliac artery angioplasty and primary stenting, J Endovasc Ther, 8, 629, 10.1177/152660280100800617 Adam, 2005, Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial, Lancet, 366, 1925, 10.1016/S0140-6736(05)67704-5